Search Results - "Iwasaki, Kosuke"

Refine Results
  1. 1

    Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study by Ohishi, Mitsuru, Yoshida, Takuo, Oh, Akinori, Hiroi, Shinzo, Takeshima, Tomomi, Otsuka, Yujiro, Iwasaki, Kosuke, Shimasaki, Yukio

    Published in Hypertension research (01-07-2019)
    “…Hypertension requires strict treatment because it causes diseases that can lead to death. Although various classes of antihypertensive drugs are available, the…”
    Get full text
    Journal Article
  2. 2

    Comparing Hospice and Nonhospice Patient Survival Among Patients Who Die Within a Three-Year Window by Connor, Stephen R., PhD, Pyenson, Bruce, FSA, MAAA, Fitch, Kathryn, RN, MA, MEd, Spence, Carol, RN, MS, Iwasaki, Kosuke, FIAJ, MAAA

    Published in Journal of pain and symptom management (01-03-2007)
    “…Abstract There is a widespread belief by some health care providers and the wider community that medications used to alleviate symptoms may hasten death in…”
    Get full text
    Journal Article
  3. 3

    Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis by Nishimura, Rimei, Takeshima, Tomomi, Iwasaki, Kosuke, Aoi, Sumiko

    Published in BMJ open (11-03-2022)
    “…ObjectivesTo compare the risk of cardiovascular events from the initiation of therapy between metformin and dipeptidyl peptidase-4 inhibitors (DPP-4i) as…”
    Get full text
    Journal Article
  4. 4

    Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database by Sruamsiri, Rosarin, Iwasaki, Kosuke, Tang, Wentao, Mahlich, Jörg

    Published in BMC dermatology (11-07-2018)
    “…Biological therapies (BTs) including infliximab (IFX), adalimumab (ADL), secukinumab (SCK) and ustekinumab (UST) are approved in Japan for the treatment of…”
    Get full text
    Journal Article
  5. 5

    Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis by Kondoh, Yasuhiro, Suda, Takafumi, Hongo, Yoshie, Yoshida, Manami, Hiroi, Shinzo, Iwasaki, Kosuke, Takeshima, Tomomi, Homma, Sakae

    Published in Respiratory research (08-02-2022)
    “…Idiopathic pulmonary fibrosis (IPF) is a cryptogenic chronic interstitial pneumonia with progressive fibrosis and a poor prognosis. A substantial number of…”
    Get full text
    Journal Article
  6. 6

    Persistence of oral antidiabetic treatment for type 2 diabetes characterized by drug class, patient characteristics and severity of renal impairment: A Japanese database analysis by Kadowaki, Takashi, Sarai, Nobuaki, Hirakawa, Takeshi, Taki, Kentaro, Iwasaki, Kosuke, Urushihara, Hisashi

    Published in Diabetes, obesity & metabolism (01-12-2018)
    “…Aim To evaluate the persistence with oral antidiabetic drug (OAD) treatment characterized by drug class, patient characteristics and severity of renal…”
    Get full text
    Journal Article
  7. 7

    Validity of Claims Diagnosis Codes for Cardiovascular Diseases in Diabetes Patients in Japanese Administrative Database by Ono, Yasuhisa, Taneda, Yusuke, Takeshima, Tomomi, Iwasaki, Kosuke, Yasui, Atsutaka

    Published in Clinical epidemiology (01-01-2020)
    “…Observational studies using large claims databases for diabetes patients have been increasingly conducted. While validation of outcomes is important in such…”
    Get full text
    Journal Article
  8. 8

    Comparison of Inconvenience Costs Between Influenza Antivirals for Japanese Pediatric Patients: A Conjoint Analysis of Parental Responses by Kurazono, Kenji, Ikeoka, Hidetoshi, Hiroi, Shinzo, Iwasaki, Kosuke, Takeshima, Tomomi, Tamura, Daisuke

    Published in Advances in therapy (01-04-2022)
    “…Introduction Certain drug characteristics, including dosage and form, are associated with either convenience or inconvenience for the patients taking them, and…”
    Get full text
    Journal Article
  9. 9

    Valvular heart disease in Japan: Characteristics and treatment of patients in acute care hospitals in 2019 by Izumi, Chisato, Matsuyama, Rei, Asaoka, Miyoshi, Iwasaki, Kosuke, Takeshima, Tomomi, Murphy, Shannon, Teng, Lida, Igarashi, Ataru

    Published in Journal of cardiology (01-07-2023)
    “…Valvular heart disease (VHD) is one of the commonest causes of cardiovascular morbidity and mortality worldwide, with acquired VHD especially prevalent in…”
    Get full text
    Journal Article
  10. 10

    Selective carboxylation of reactive benzylic C-H bonds by a hypervalent iodine(III)/inorganic bromide oxidation system by Dohi, Toshifumi, Ueda, Shohei, Iwasaki, Kosuke, Tsunoda, Yusuke, Morimoto, Koji, Kita, Yasuyuki

    Published in Beilstein journal of organic chemistry (16-05-2018)
    “…An oxidation system comprising phenyliodine(III) diacetate (PIDA) and iodosobenzene with inorganic bromide, i.e., sodium bromide, in an organic solvent led to…”
    Get full text
    Journal Article
  11. 11

    Estimation of the cost of influenza antiviral medication guidance or support provided by healthcare professionals: a questionnaire survey in Japan by Kurazono, Kenji, Ikeoka, Hidetoshi, Hiroi, Shinzo, Iwasaki, Kosuke, Takeshima, Tomomi, Akazawa, Manabu

    Published in Journal of medical economics (01-01-2022)
    “…To estimate the cost of antiviral medication guidance and/or support from the perspective of healthcare professionals by administration route (oral or…”
    Get more information
    Journal Article
  12. 12

    Patterns of anti-vascular endothelial growth factor treatment for chorioretinal vascular diseases: Analysis of a nationwide claims database in Japan by Gomi, Fumi, Kawasaki, Ryo, Ogura, Yuichiro, Iwasaki, Kosuke, Takeshima, Tomomi, Yamabe, Masafumi, Imai, Kota

    Published in Annals of Clinical Epidemiology (2024)
    “…BACKGROUNDAlthough intravitreal anti-vascular endothelial growth factor therapy is currently considered the first-line treatment for chorioretinal vascular…”
    Get full text
    Journal Article
  13. 13

    Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes by Nagai, Yoshio, Kazumori, Kiyoyasu, Takeshima, Tomomi, Iwasaki, Kosuke, Tanaka, Yasushi

    Published in Diabetes therapy (01-03-2021)
    “…Introduction Metformin has dose-dependent hypoglycemic effects on patients with type 2 diabetes (T2D). In Japan, metformin has been prescribed at lower doses…”
    Get full text
    Journal Article
  14. 14

    A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes by Nagai, Yoshio, Kazumori, Kiyoyasu, Takeshima, Tomomi, Iwasaki, Kosuke, Tanaka, Yasushi

    Published in Diabetes therapy (01-04-2021)
    “…Introduction Patients with type 2 diabetes (T2D) in Japan are prescribed a lower dose of metformin that their counterparts in Western countries due to concerns…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database by Kawachi, Izumi, Okamoto, Shuichi, Sakamoto, Mariko, Ohta, Hiroyuki, Nakamura, Yusuke, Iwasaki, Kosuke, Yoshida, Manami, Hiroi, Shinzo, Ogino, Mieko

    Published in BMC neurology (16-12-2019)
    “…In this study, we aimed to understand the trends in total and itemized medical expenses, especially of disease-modifying therapy (DMT), for multiple sclerosis…”
    Get full text
    Journal Article
  17. 17

    Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data by Hiroi, Shinzo, Shimasaki, Yukio, Kikuchi, Takashi, Otsuka, Yujiro, Iwasaki, Kosuke, Ohishi, Mitsuru

    Published in Hypertension research (01-12-2016)
    “…Combination therapy using two or three classes of drugs is often required to treat hypertension to prevent cardiovascular disease. In this study, we examined…”
    Get full text
    Journal Article
  18. 18

    Patient Characteristics, Treatment Patterns and Outcomes Among Relapsed/Refractory Multiple Myeloma (RRMM) Patients in Japan by Jun, Gyungjin, Luptakova, Katarina, Koizumi, Hiroo, Iwasaki, Kosuke, Hiroi, Shinzo, Soeda, Junpei

    Published in Blood (02-12-2016)
    “…Background MM is one of the most common hematologic malignancies in Japan and deaths due to MM represent 1.1% of all cancer deaths in 2014. Proteasome…”
    Get full text
    Journal Article
  19. 19

    Medical cost, incidence rate, and treatment status of gastroesophageal reflux disease in Japan: analysis of claims data by Miwa, Hiroto, Takeshima, Tomomi, Iwasaki, Kosuke, Hiroi, Shinzo

    Published in Journal of medical economics (01-11-2016)
    “…Published reports have shown the prevalence and incidence of gastroesophageal reflux disease (GERD) is increasing in Japan. The objective of this study is to…”
    Get more information
    Journal Article
  20. 20

    Non‐ergot dopamine agonist therapy for Parkinson's disease in Japan: A claims database analysis by Wada‐Isoe, Kenji, Tsuboi, Yoshio, Kondo, Hiroyuki, Kojima, Yoshitsugu, Takeshima, Tomomi, Iwasaki, Kosuke

    Published in Neurology and clinical neuroscience (01-03-2023)
    “…Background Levodopa monotherapy and combination therapy with non‐ergot dopamine agonists (DAs; pramipexole, ropinirole, and rotigotine) are commonly used in…”
    Get full text
    Journal Article